KE3722A - Sustained release theophylline tablet having reduced bulk - Google Patents

Sustained release theophylline tablet having reduced bulk

Info

Publication number
KE3722A
KE3722A KE3722A KE372287A KE3722A KE 3722 A KE3722 A KE 3722A KE 3722 A KE3722 A KE 3722A KE 372287 A KE372287 A KE 372287A KE 3722 A KE3722 A KE 3722A
Authority
KE
Kenya
Prior art keywords
sustained release
reduced bulk
release theophylline
theophylline tablet
theophylline
Prior art date
Application number
KE3722A
Other languages
English (en)
Inventor
T David Stephen
Brooks Dana
E Gallian Claude
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of KE3722A publication Critical patent/KE3722A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
KE3722A 1980-05-06 1987-03-31 Sustained release theophylline tablet having reduced bulk KE3722A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14742980A 1980-05-06 1980-05-06
US24978781A 1981-04-01 1981-04-01

Publications (1)

Publication Number Publication Date
KE3722A true KE3722A (en) 1987-04-30

Family

ID=26844921

Family Applications (1)

Application Number Title Priority Date Filing Date
KE3722A KE3722A (en) 1980-05-06 1987-03-31 Sustained release theophylline tablet having reduced bulk

Country Status (17)

Country Link
AT (1) AT380789B (enExample)
AU (1) AU549299B2 (enExample)
CA (1) CA1165241A (enExample)
CY (1) CY1368A (enExample)
DE (1) DE3117756A1 (enExample)
DK (1) DK155976C (enExample)
FI (1) FI811356L (enExample)
FR (1) FR2484253A1 (enExample)
GB (1) GB2078518B (enExample)
HK (1) HK4288A (enExample)
IE (1) IE51157B1 (enExample)
IT (1) IT1209867B (enExample)
KE (1) KE3722A (enExample)
LU (1) LU83342A1 (enExample)
NL (1) NL8102168A (enExample)
SE (1) SE452550B (enExample)
SG (1) SG30987G (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4547358A (en) * 1980-05-06 1985-10-15 Mead Johnson & Company Sustained release tablet containing at least 95 percent theophylline
US4503031A (en) * 1982-12-17 1985-03-05 Glassman Jacob A Super-fast-starting-sustained release tablet
HU187215B (en) * 1983-01-26 1985-11-28 Egyt Gyogyszervegyeszeti Gyar Method for producing pharmaceutical product of high actor content and prolonged effect
US4753945A (en) * 1986-02-19 1988-06-28 Eye Research Institute Of Retina Foundation Stimulation of tear secretion with phosphodiesterase inhibitors
FR2595945B1 (fr) * 1986-03-19 1990-01-19 Doms Laboratoires Comprime-retard de theophylline a base de p.v.c., et son procede de preparation
USD557612S1 (en) * 2006-04-10 2007-12-18 Parfums Christian Dior Flask for a cosmetic product

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE636568A (enExample) * 1961-01-31
DE1228029C2 (de) * 1964-05-09 1973-05-17 Merck Ag E Verfahren zur Herstellung von Tabletten durch Pressen von Pulvergemischen ohne vorhergehende Granulation
US3723614A (en) * 1971-01-06 1973-03-27 Ciba Geigy Ag Maltese-cross scored tablet
US4264573A (en) * 1979-05-21 1981-04-28 Rowell Laboratories, Inc. Pharmaceutical formulation for slow release via controlled surface erosion

Also Published As

Publication number Publication date
AT380789B (de) 1986-07-10
FR2484253B1 (enExample) 1983-06-03
DE3117756C2 (enExample) 1992-11-26
SE452550B (sv) 1987-12-07
AU549299B2 (en) 1986-01-23
DE3117756A1 (de) 1982-04-29
IT8148406A0 (it) 1981-05-06
GB2078518B (en) 1984-04-11
DK200181A (da) 1981-11-07
AU7020581A (en) 1981-11-12
IT1209867B (it) 1989-08-30
SE8102814L (sv) 1981-11-07
FR2484253A1 (fr) 1981-12-18
LU83342A1 (fr) 1982-01-20
FI811356A7 (fi) 1981-11-07
DK155976C (da) 1989-10-30
SG30987G (en) 1987-07-17
ATA202081A (de) 1985-12-15
IE51157B1 (en) 1986-10-15
CY1368A (en) 1987-08-07
CA1165241A (en) 1984-04-10
FI811356L (fi) 1981-11-07
IE810989L (en) 1981-11-06
DK155976B (da) 1989-06-12
GB2078518A (en) 1982-01-13
HK4288A (en) 1988-01-29
NL8102168A (nl) 1981-12-01

Similar Documents

Publication Publication Date Title
ES429928A1 (es) Procedimiento para producir una estructura conformada, con-tigua, desprendedora de cloro soluble.
BG49717A3 (bg) Метод за получаване на хирудин
HUT37614A (en) Process for producing piridazinamines of antiviral activity and pharmaceutical compositions containing them as active agents
ES8305285A1 (es) Procedimiento para la obtencion de polimerizados lineales basicos.
GB2094145B (en) Stabilized insulin preparations and method for their production
DK468288A (da) Antivirale forbindelser
IT1195297B (it) Composti xantati antivirali,procedimento per la loro produzione e composizioni farmaceutiche che li contengono
HK4288A (en) Sustained release theophylline tablet having reduced bulk
PT77581A (fr) Procede pour preparer et fabriquer des comprimes de theophyline a liberation controlee
EP0011490A3 (en) Analgesic tablet and process for its preparation
IT1209896B (it) Antibiotico bmg162-af2 procedimento per la sua produzione e medicinale antitumorale contenente il suddetto antibiotico come ingrediente attivo
FR2350798A1 (fr) Dispositif d'alimentation d'objets en forme de tiges, tels que notamment des cigarettes
BE891557A (fr) Procede de preparation de comprimes analgesiques, directement compressibles, d'acetaminophene renfermant de la carboxyme-thylcellulose sodique et nouveaux produits ainsi obtenus
IT1098345B (it) Derivati dell'acido aminobenzoico,procedimento per la loro preparazione e prodotti medicinali contenenti tali derivati dell'acido aminobenzoico
FR2339397A1 (fr) Nouveaux ethers d'oximes, procede de preparation de ceux-ci et medicaments les contenant
BE866488A (fr) Procede de dosage global d'hormones et de produits pharmaceutiques
ES2128313T3 (es) Naftalimidas n-substituidas, su obtencion y empleo.
ES8502435A1 (es) Un metodo para preparar 2(1h)-piridinonas
ES468938A1 (es) Metodo de preparacion de auranofin.
BE894597A (fr) Nouvelles xanthines a activite pharmacologique, leur procede d'obtention, les compositions pharmaceutiques les contenant et leur utilisation en medecine humaine
DK0497177T3 (da) Vitaminholdige formuleringer og fremstilling deraf
FR2620435B1 (fr) Agglomeres solides, a base de chlorate de sodium, degageant de l'oxygene respirable par decomposition thermochimique et leur procede de preparation
FR2366279A1 (fr) Acides 5-alkoxy-picoliniques, procede pour leur preparation et composition anti-hypertensive contenant des acides 5-alkoxy-picolinique
IE782540L (en) Tablets containing¹1,3-bis(2-carboxychromon-5-yloxy)-2-hydroxypropane
GB1260556A (en) Improvements in or relating to the manufacture of perborates